Wells Fargo & Company »

Iteos Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Iteos Therapeutics (ITOS) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Iteos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iteos Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iteos Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $137k 10k 13.64
2023-12-31 $84k 7.7k 10.96
2023-09-30 $237k 22k 10.95
2023-06-30 $336k 25k 13.24
2022-12-31 $14k 713 19.53
2022-09-30 $42k 2.2k 18.88
2022-06-30 $51k 2.4k 20.76
2022-03-31 $90k 2.8k 31.93
2021-12-31 $389k 8.4k 46.59
2021-09-30 $0 60k 0.00
2021-06-30 $5.1k 216 23.58
2021-03-31 $64k 1.9k 34.39
2020-12-31 $264k 7.8k 33.85
2020-09-30 $195k 7.9k 24.67